[1] 鲁攀攀,李荥娟,马彬彬,等.老年髋部骨折患者术前营养状况的研究进展[J].东南大学学报(医学版),2020,39(1):100-105.
[2] ALZAHRANI K,GANDHI R,DAVIS A,et al.In-hospital mortality following hip fracture care in southern Ontario[J].Can J Surg,2010,53(5):294-298.
[3] JORDAN M,AGUILERA X,GONZÁLEZ J C,et al.Prevention of postoperative bleeding in hip fractures treated with prosthetic replacement:efficacy and safety of fibrin sealant and tranexamic acid.A randomised controlled clinical trial(TRANEXFER study)[J].Arch Orthop Trauma Surg,2019,139(5):597-604.
[4] CHATTERTON B D,MOORES T S,AHMAD S,et al.Cause of death and factors associated with early in-hospital mortality after hip fracture[J].Bone Joint J,2015,97-B(2):246-251.
[5] DILLON M F,COLLINS D,RICE J,et al.Preoperative characteristics identify patients with hip fractures at risk of transfusion[J].Clin Orthop Relat Res,2005,439(439):201-206.
[6] RASKIN SHAKYA,亓一鸣,芮云峰,等.氨甲环酸在全髋关节置换术中的应用进展[J].东南大学学报(医学版),2018(1):137-141.
[7] TENGBERG P T,FOSS N B,PALM H,et al.Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip:results of a randomised controlled trial[J].Bone Joint J,2016,98-B(6):747.
[8] HUANG F,ZHAO Q,GUO C,et al.Use of aprotinin to reduce blood loss and transfusion in major orthopedic surgery:a meta-analysis[J].Transfus Apher Sci,2014,51(2):152-161.
[9] CARSON J L,STANWORTH S J,ROUBINIAN N,et al.Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion[J].Cochrane Database Syst Rev,2016,10(10):CD002042.
[10] 中国康复技术转化及发展促进会,中国研究型医院学会关节外科学专业委员会,中国医疗保健国际交流促进会关节疾病防治分会,等.中国骨科手术加速康复围手术期氨甲环酸与抗凝血药应用的专家共识[J].中华骨与关节外科杂志,2019,12(2):81-88.
[11] JENNINGS J D,SOLARZ M K,HAYDEL C.Application of tranexamic acid in trauma and orthopedic surgery[J].Orthop Clin North Am,2016,47(1):137-143.
[12] JIANG W M,LI Y.Tranexamic acid can reduce blood loss in patients undergoing intertrochanteric fracture surgery:A meta-analysis[J].Medicine,2019,98(11):e14564.
[13] ZHOU X,ZHANG Y,LIFENG J,et al.Efficacy and safety of tranexamic acid in intertrochanteric fractures:a single-blind randomized controlled trial[J].Orthopaedic Surgery,2019,11(4):635-642.
[14] LEI J,ZHANG B,CONG Y,et al.Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA:a single-center randomized controlled trial[J].J Orthop Surg Res,2017,12(1):124.
[15] MOHIB Y,RASHID R H,ALI M,et al.Does tranexamic acid reduce blood transfusion following surgery for inter-trochanteric fracture? A randomized control trial[J].J Pak Med Assoc,2015,65(11 Suppl 3):S17-20.
[16] TIAN S,SHEN Z,LIU Y,et al.The effect of tranexamic acid on hidden bleeding in older intertrochanteric fracture patients treated with PFNA[J].Injury,2018,49(3):680-684.
[17] BENONI,G,LETHAGEN S,NILSSON P,et al.Tranexamic acid,given at the end of the operation,does not reduce postoperative blood loss in hip arthroplasty[J].Acta Orthop Scand,2000,71(3):250-254.
[18] WANG W,YU J.Tranexamic acid reduces blood loss in intertrochanteric fractures:A meta-analysis from randomized controlled trials[J].Medicine,2017,96(52):e9396.
[19] DRAKOS A,RAOULIS V,KARATZIOS K,et al.Efficacy of local administration of tranexamic acid for blood salvage in patients undergoing intertrochanteric fracture surgery[J].J Orthop Trauma,2016,30(8):409-414.
[20] VIRANI S R,DAHAPUTE A A,PANDA I,et al.Role of local infiltration of tranexamic acid in reducing blood loss in peritrochanteric fracture surgery in the elderly population[J].Malays Orthop J,2016,10(3):26-30.
[21] GEORGI P,GEORGIEV A,PANAYOT P,et al.Comparison of topical and intravenous administration of tranexamic acid for blood loss control during total joint replacement:Review of literature[J].J Orthop Translat,2018,13:7-12.
[22] 张连方,朱锋,周军,等.氨甲环酸减少股骨粗隆间骨折PFNA围术期失血[J].中国矫形外科杂志,2017,25(24):2248-2250.
[23] 郑志辉,陈晟,关可立,等.股骨近端防旋髓内钉内固定治疗股骨转子间骨折失血量与静脉联合局部应用氨甲环酸的关系[J].中国组织工程研究,2020(9):1359-1364.
[24] GULABI D,YUCEL Y,ERKAL K H,et al.The combined administration of systemic and topical tranexamic acid for total hip arthroplasty:Is it better than systemic?[J].Acta Orthop Traumatol Turc,2019,53(4):297-300.
[25] ASTEDT B,LIEDHOLM P,WINGERUP L.The effect of tranexamic acid on the fibrinolytic activity of vein walls[J].Annales Chirurgiae Et Gynaecologiae,1978,67(6):203.
[26] MANNUCCI P M.Hemostatic drugs[J].N Engl J Med,1998,339(4):245-253.
[27] GEERTS W H,CODE K I,JAY R M,et al.A prospective study of venous thromboembolism after major trauma[J].N Engl J Med,1994,331(24):1601-1606.
[28] GAUSDEN E B,QUDSI R,BOONE M D,et al.Tranexamic acid in orthopaedic trauma surgery:a meta-analysis[J].J Orthop Trauma,2017,31(10):513-519.
[29] XING F,CHEN W,LONG C,et al.Postoperative outcomes of tranexamic acid use in geriatric trauma patients treated with proximal femoral intramedullary nails:A systematic review and meta-analysis[J].Orthop Traumatol Surg Res,2020,106(1):117-126.
[30] QIANZHENG Z,CAIXIA Y,XINGZUO C,et al.Efficacy and safety of tranexamic acid for blood salvage in intertrochanteric fracture surgery:a meta-analysis[J].Clin Appl Thromb Hemost,2018,24(8):1189-1198.
[31] BROSS M H,SOCH K,SMITH-KNUPPEL T.Anemia in older persons[J].Am Fam Physician,2010,82(5):480-487.
[32] LUO Z Y,WANG H Y,WANG D,et al.Oral vs intravenous vs topical tranexamic acid in primary hip arthroplasty:a prospective,randomized,double-blind,controlled study[J].J Arthroplasty,2018,33(3):786-793.
[33] YU C C,KADRI O,KADADO A,et al.Intravenous and oral tranexamic acid are equivalent at reducing blood loss in thoracolumbar spinal fusion:a prospective randomized trial[J].Spine,2019,44(11):755-761.
[34] KAYUPOV E,FILLINGHAM Y A,OKROJ K,et al.Oral and intravenous tranexamic acid are equivalent at reducing blood loss following total hip arthroplasty[J].J Bone Joint Surg,2017,99(5):373-378.
[35] QI Y M,WANG H P,LI Y J,et al.The efficacy and safety of intravenous tranexamic acid in hip fracture surgery:A systematic review and meta-analysis[J].J Orthop Translat,2019,19:1-11. |
